Antinociceptive properties of a selective non-nucleotide P2X 3/P2X2/3 receptor antagonist

Drug News and Perspectives

Volumn 18, Issue 8, 2005, Pages 501-507

  McGaraughty, Steve ^a   Jarvis, Michael F ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A 317491; NALOXONE; OPIATE ANTAGONIST; PURINE P2X2 RECEPTOR; PURINE P2X3 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; A-317491; ANALGESIC AGENT; PHENOL DERIVATIVE; POLYCYCLIC HYDROCARBON; PURINE P2 RECEPTOR;

ANALGESIA; ANTINOCICEPTION; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; DOSE RESPONSE; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; HUMAN; HYPERALGESIA; NEUROPATHIC PAIN; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PAIN; POSTOPERATIVE PAIN; REVIEW; ANIMAL; DRUG ANTAGONISM; DRUG SCREENING;

ANALGESICS; ANIMALS; DRUG EVALUATION, PRECLINICAL; HYPERALGESIA; PAIN; PHENOLS; POLYCYCLIC COMPOUNDS; RECEPTORS, PURINERGIC P2;

EID: 30744455257     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2005.18.8.942082     Document Type: Review

References (61)

1. Julius, D. and Basbaum, A.I. Molecular mechanisms of nociception. Nature 2001, 413: 203-10.
2. Woolf, C.J. and Salter, M.W. Neuronal plasticity: Increasing the gain in pain. Science 2000, 288: 1765-9.
3. Burnstock, G. A unifying purinergic hypothesis for the initiation of pain. Lancet 1996, 347: 1604-5.
4. Burnstock, G. and Wood, J.N. Purinergic receptors: Their role in nociception and primary afferent neurotransmission. Curr Opin Neurobiol 1996, 6: 526-32.
5. Cook, S.P. and McCleskey, E.W. Cell damage excites nociceptors through release of cytosolic ATP. Pain 2002, 95: 41-7.
6. Holton, F.A. and Holton, P.J. The capillary dilator substances in dry powders of spinal roots: A possible role for adenosine triphosphate in chemical transmission from nerve endings. J Physiol 1954, 126: 124-40.
7. Holton, P. The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves. J Physiol 1959, 145: 494-504.
8. Bland-Ward, P.A. and Humphrey, P.P. Acute nociception mediated by hindpaw P2X receptor activation in the rat. Br J Pharmacol 1997, 122: 365-71.
9. Driesen, B., Reimann, W., Selve, N., Friderichs, E. and Bultmann, R. Antinociceptive effect of intrathecally administered P2-purinoceptor antagonists in rats. Brain Res 1994, 666: 182-8.
10. Jarvis, M.F., Wismer, C.T., Schweitzer, E. et al. Modulation of BzATP and formalin induced nociception: Attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X(3) allosteric modulator, cibacron blue. Br J Pharmacol 2001, 132: 259-69.
11. Wismer, C.T., Faltynek, C.R., Jarvis, M.F. and McGaraughty, S. Distinct neurochemical mechanisms are activated following administration of different P2X receptor agonists into the hindpaw of a rat. Brain Res 2003, 965: 187-93.
12. Tsuda, M., Koizumi, S., Kita, A., Shigemoto, Y., Ueno, S. and Inoue, K. Mechanical allodynia caused by intraplantar injection of P2X receptor agonist in rats: Involvement of heteromeric P2X2/3 receptor signaling in capsaicin-insensitive primary afferent neurons. J Neurosci 2000, 20: RC90.
13. Hamilton, S.G., McMahon, S.B. and Lewin, G.R. Selective activation of nociceptors by P2X receptor agonists in normal and inflamed rat skin. J Physiol 2001, 534: 437-45.
14. Sawynok, J. and Reid, A. Peripheral adenosine 5′-triphosphate enhances nociception in the formalin test via activation of a purinergic P2X receptor. Eur J Pharmacol 1997, 330: 115-21.
15. Bianchi, B.R., Lynch, K.J., Tourna, E. et al. Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur J Pharmacol 1999, 376: 127-38.
16. Jacobson, K.A., Jarvis, M.F. and Williams, M. Purine and pyrimidine (P2) receptors as drug targets. J Med Chem 2002, 45: 4057-93.
17. Ralevic, V. and Burnstock, G. Receptors for purines and pyrimidines. Pharmacol Rev 1998, 50: 413-92.
18. Abbracchio, M.P., Boeynaems, J.M., Barnard, E.A. et al. Characterization of the UDP-glucose receptor (re-named here the P2Y(14) receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 2003, 24: 52-5.
19. Collo, G., North, R.A., Kawashima, E., Merlo-Pich, E., Neidhart, S., Surprenant, A. and Buell, G. Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci 1996, 16: 2495-507.
20. Cockayne, D.A., Hamilton, S.G., Zhu, Q.M. et al. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 2000, 407: 1011-5.
21. Okada, M., Nakagawa, T., Minami, M. and Satoh, M. Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats. J Pharmacol Exp Ther 2002, 303: 66-73.
22. Souslova, V., Cesare, P., Ding, Y. et al. Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature 2000, 407: 1015-7.
23. Tsuda, M., Shigemoto-Mogami, Y., Koizumi, S., Mizokoshi, A., Kohsaka, S., Salter, M.W. and Inoue, K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 2003, 424: 778-83.
24. Vulchanova, L., Arvidsson, U., Riedl, M. et al. Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry. Proc Natl Acad Sci 1996, 93: 8063-7.
25. Vulchanova, L., Ried, M.S., Shuster, S.J., Buell, G., Surprenant, A., North, R.A. and Elde, R. Immunohistochemical study of the P2X2 and P2X3 receptor subunits in rat and monkey sensory neurons and their central terminals. Neuropharmacology 1997, 36: 1229-42.
26. Yoshida, K., Nakagawa, T., Kaneko, S., Akaike, A. and Satoh, M. Adenosine 5′-triphosphate inhibits slow depolarization induced by repetitive dorsal root stimulation via P2Y purinoceptors in substantia gelatinosa neurons of the adult rat spinal cord slices with the dorsal root attached. Neurosci Lett 2002, 320: 121-4.
27. North, R.A. P2X3 receptors and peripheral pain mechanisms. J Physiol 2004, 554: 301-8.
28. Burgard, E.C., Niforatos, W., Van Biesen, T. et al. P2X receptor-mediated ionic currents in dorsal root ganglion neurons. J Neurophysiol 1999, 82: 1590-8.
29. Rae, M.G., Rowan, E.G. and Kennedy, C. Pharmacological properties of P2X3-receptors present in neurones of the rat dorsal root ganglia. Br J Pharmacol 1998, 124: 176-80.
30. Bradbury, E.J., Burnstock, G. and McMahon, S.B. The expression of P2X3 purinoreceptors in sensory neurons: Effects of axotomy and glial-derived neurotrophic factor. Mol Cell Neurosci 1998, 12: 256-68.
31. Chen, C.C., Akopian, A.N., Sivilotti, L., Colquhoun, D., Burnstock, G. and Wood, J.N. A P2Xpurinoceptor expressed by a subset of sensory neurons. Nature 1995, 377: 428-31.
32. Novakovic, S.D., Kassotakis, L.C., Oglesby, I.B., et al. Immunocytochemical localization of P2X3 purinoceptors in sensory neurons in naive rats and following neuropathic injury. Pain 1999, 80: 273-82.
33. Barclay, J., Patel, S., Dorn, G. et al. Functional downregulation of P2X3 receptor subunit in rat sensory neurons reveals a significant role in chronic neuropathic and inflammatory pain. J Neurosci 2002, 22: 8139-47.
34. Honore, P., Kage, K., Mikusa, J. et al. Analgesic profile of intrathecal P2X3 antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats. Pain 2002, 99: 11-9.
35. Fukuhara, N., Imai, Y., Sakakibara, A., Monta, K., Kitayama, S., Tanne, K. and Dohi, T. Regulation of the development of allodynia by intrathecally administered P2 purinoceptor agonists and antagonists in mice. Neurosci Lett 2000, 292: 25-8.
36. Liu, T. and Tracey, D.J. ATP P2X receptors play little role in the maintenance of neuropathic hyperalgesia. Neuroreport 2000, 11: 1669-72.
37. Stanfa, L.C., Kontinen, V.K. and Dickenson, A.H. Effects of spinally administered P2X receptor agonists and antagonists on the responses of dorsal horn neurones recorded in normal, carrageenan-inflamed and neuropathic rats. Br J Pharmacol 2000, 129: 351-9.
38. Tsuda, M., Ueno, S. and Inoue, K. In vivo pathway of thermal hyperalgesia by intrathecal administration of alpha,beta-methylene ATP in mouse spinal cord: Involvement of the glutamate-NMDA receptor system. Br J Pharmacol 1999, 127: 449-56.
39. Tsuda, M., Ueno, S. and Inoue, K. Evidence for the involvement of spinal endogenous ATP and P2X receptors in nociceptive responses caused by formalin and capsaicin in mice. Br J Pharmacol 1999, 128: 1497-504.
40. Zheng, J.H. and Chen, J. Modulatory roles of the adenosine triphosphate P2x-purinoceptor in generation of the persistent nociception induced by subcutaneous bee venom injection in the conscious rat. Neurosci Lett 2000, 278: 41-4.
41. Jarvis, M.F., Burgard, E.C., McGaraughty, S. et al. A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Natl Acad Sci 2002, 99: 17179-84.
42. Neelands, T.R., Burgard, E.C., Uchic, M.E. et al. 2′,3′-O-(2, 4,6,trinitrophenyl)-ATP and A-317491 are competitive antagonists at a slowly desensitizing chimeric human P2X3 receptor. Br J Pharmacol 2003, 140: 202-10.
43. McGaraughty, S., Honore, P., Wismer, C.T. et al. Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain. Br J Pharmacol 2005, 146: 180-8.
44. Wu, G., Whiteside, G.T., Lee, G., Nolan, S., Niosi, M., Pearson, M.S. and Ilyin, V.I. A-317491, a selective P2X3/P2X(2/3) receptor antagonist, reverses inflammatory mechanical hyperalgesia through action at peripheral receptors in rats. Eur J Pharmacol 2004, 504: 45-53.
45. Kage, K., Niforatos, W., Zhu, C.Z., Lynch, K.J., Honore, P. and Jarvis, M.F. Alteration of dorsal root ganglion P2X3 receptor expression and function following spinal nerve ligation in the rat. Exp Brain Res 2002, 147: 511-9.
46. Xu, G.Y. and Huang, L.Y. Peripheral inflammation sensitizes P2X receptor-mediated responses in rat dorsal root ganglion neurons. J Neurosci 2002, 22: 93-102.
47. Llewellyn-Smith, I.J. and Burnstock, G. Ultrastructural localization of P2X3 receptors in rat sensory neurons. Neuroreport 1998, 9: 2245-50.
48. Cook, S.P., Vulchanova, L., Haargreaves, K.M., Elde, R. and McCleskey, E.W. Distinct ATP receptors on pain-sensing and stretch-sensing neurons. Nature 1997, 387: 505-8.
49. Vulchanova, L., Ried, M.S., Shuster, S.J. et al. P2X3 is expressed by DRG neurons that terminate in inner lamina II. Eur J Neurosci 1998, 10: 3470-8.
50. McGaraughty, S., Wismer, C.T., Zhu, C.Z. et al. Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration. Br J Pharmacol 2003, 140: 1381-8.
51. Dickenson, A.H. and Sullivan, A.F. Subcutaneous formalin-induced activity of dorsal horn neurones in the rat: Differential response to an intrathecal opiate administered pre or post formalin. Pain 1987, 30: 349-60.
52. Huber, J.D., Witt, K.A., Horn, S., Egleton, R.D., Mark, K.S. and Davis, T.P. Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. Am J Physiol Heart Circ Physiol 2001, 280: H1241-8.
53. Fukui, M., Takishita, A., Zhang, N., Nakagawa, T., Minami, M. and Satoh, M. Involvement of locus coeruleus noradrenergic neurons in supraspinal antinociception by alpha,beta-methylene-ATP in rats. J Pharmacol Sci 2004, 94: 153-60.
54. Yao, S.T., Barden, J.A., Finkelstein, D.I., Bennett, M.R. and Lawrence, A.J. Comparative study on the distribution patterns of P2X(1)-P2X(6) receptor immunoreactivity in the brainstem of the rat and the common marmoset (Callithrix jacchus): Association with catecholamine cell groups. J Comp Neurol 2000, 427: 485-507.
55. Gu, J.G. and MacDermott, A.B. Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses. Nature 1997, 389: 749-53.
56. Hugel, S. and Schlichter, R. Presynaptic P2X receptors facilitate inhibitory GABAergic transmission between cultured rat spinal cord dorsal horn neurons. J Neurosci 2000, 20: 2121-30.
57. Nakatsuka, T., Mena, N., Lingm, J. and Gum, J.G. Depletion of substance P from rat primary sensory neurons by ATP, an implication of P2X receptor-mediated release of substance P. Neuroscience 2001, 107: 293-300.
58. Ueda, H., Matsunaga, S., Inoue, M., Yamamoto, Y. and Hazato, T. Complete inhibition of purinoceptor agonist-induced nociception by spinorphin, but not by morphine. Peptides 2000, 21: 1215-21.
59. Bian, D., Nichols, M.L., Ossipov, M.H., Lai, J. and Porreca, F. Characterization of the antiallodynic efficacy of morphine in a model of neuropathic pain in rats. Neuroreport 1995, 6: 1981-4.
60. Lee, Y.W., Chaplan, S.R. and Yaksh, T.L. Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model. Neurosci Lett 1995, 199: 111-4.
61. Ossipov, M.H., Lopez, Y., Nichols, M.L., Bian, D. and Porreca, F. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive. Neurosci Lett 1995, 199: 87-90.